[go: up one dir, main page]

WO2003033668A3 - Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis - Google Patents

Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis Download PDF

Info

Publication number
WO2003033668A3
WO2003033668A3 PCT/US2002/033311 US0233311W WO03033668A3 WO 2003033668 A3 WO2003033668 A3 WO 2003033668A3 US 0233311 W US0233311 W US 0233311W WO 03033668 A3 WO03033668 A3 WO 03033668A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumorigenesis
correlation
gene expression
ataxia telangiectasia
chromosome abnormalities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/033311
Other languages
French (fr)
Other versions
WO2003033668A2 (en
Inventor
Carrolee Barlow
Christopher J Winrow
Marie Lei A Callahan
Daniel G Pankratz
Cecile Rose T Vibat
Amy J Warren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Digital Gene Technologies Inc
Original Assignee
Digital Gene Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digital Gene Technologies Inc filed Critical Digital Gene Technologies Inc
Priority to AU2002349956A priority Critical patent/AU2002349956A1/en
Priority to EP02786436A priority patent/EP1608390A2/en
Publication of WO2003033668A2 publication Critical patent/WO2003033668A2/en
Anticipated expiration legal-status Critical
Publication of WO2003033668A3 publication Critical patent/WO2003033668A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Polynucleotides, polypeptides, kits and methods are provided related to regulated genes characteristic of ataxia telangiectasia tumorigenesis.
PCT/US2002/033311 2001-10-17 2002-10-17 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis Ceased WO2003033668A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002349956A AU2002349956A1 (en) 2001-10-17 2002-10-17 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis
EP02786436A EP1608390A2 (en) 2001-10-17 2002-10-17 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33020601P 2001-10-17 2001-10-17
US60/330,206 2001-10-17

Publications (2)

Publication Number Publication Date
WO2003033668A2 WO2003033668A2 (en) 2003-04-24
WO2003033668A3 true WO2003033668A3 (en) 2004-09-16

Family

ID=23288744

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/033311 Ceased WO2003033668A2 (en) 2001-10-17 2002-10-17 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis

Country Status (3)

Country Link
EP (1) EP1608390A2 (en)
AU (1) AU2002349956A1 (en)
WO (1) WO2003033668A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034144B2 (en) 1997-05-13 2006-04-25 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
US7105294B2 (en) 1998-05-04 2006-09-12 Dako Denmark A/S Method and probes for the detection of chromosome aberrations

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BISHOP A. ET AL: "Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice", CANCER RESEARCH, vol. 60, no. 2, 15 January 2000 (2000-01-15), pages 395 - 399, XP002978686 *
DATABASE GENBANK [online] 17 December 1998 (1998-12-17), MARRA ET AL: "The WashU-HHMI Mouse EST Project", XP002978683, accession no. EST Database accession no. (AI315667) *
DATABASE GENBANK [online] 30 June 2000 (2000-06-30), OSADA ET AL: "Isolation of full-length cDNA clones from mouse brain cDNA library made by oligo-capping method", XP002978684, accession no. EST Database accession no. (AB041555) *
LIYANAGE M. ET AL: "Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice", BLOOD, vol. 96, no. 5, 1 September 2000 (2000-09-01), pages 1940 - 1946, XP002978685 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034144B2 (en) 1997-05-13 2006-04-25 Erasmus Universiteit Rotterdam Molecular detection of chromosome aberrations
US7105294B2 (en) 1998-05-04 2006-09-12 Dako Denmark A/S Method and probes for the detection of chromosome aberrations
US7368245B2 (en) 1998-05-04 2008-05-06 Dako Denmark A/S Method and probes for the detection of chromosome aberrations
US7642057B2 (en) 1998-05-04 2010-01-05 Dako Denmark A/S Method and probes for the detection of chromosome aberrations

Also Published As

Publication number Publication date
AU2002349956A1 (en) 2003-04-28
EP1608390A2 (en) 2005-12-28
WO2003033668A2 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
WO2005054508A3 (en) Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
AU2003256703A1 (en) Biosensor arrays and methods
AU2003304203A1 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
WO2004072294A3 (en) Methods and means for nucleic acid sequencing
AU2003259285A1 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2004047514A3 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2003290432A1 (en) T cell activating gene
WO2004043232A3 (en) Methods for identifying risk of melanoma and treatments thereof
AU2001264935A1 (en) Method for introducing and expressing genes in animal cells, and bacterial blebsfor use in same
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
TW200506052A (en) Method of analyzing DNA region
WO2003033668A3 (en) Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis
EP1567644A4 (en) Tissue specific genes and gene clusters
AU2001279561A1 (en) Method of selection in host cells with eliminated dna sequences
WO2004048546A3 (en) Methods for identifying risk of breast cancer and treatments thereof
AU2003244340A1 (en) Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system.
AU2003267513A8 (en) Chromosome 3, 5 and 11 genes involved in premature canities
WO2004000999A3 (en) Identification of a receptor controlling migration and metastasis of skin cancer cells
WO2002010203A3 (en) Daz genes
AU2003284985A1 (en) Production of vanillin in microbial cells
WO2003030719A3 (en) Methods and kits for use in selecting approaches to treating cancer
AU2003275946A1 (en) Gene expression in biological conditions
HK1045327A1 (en) Gene expression modulated in gastrointestinal inflammation
AU2002321858A1 (en) Method of determining blood-relationship by typing str alleles on the x chromosome and dna typing kit using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002786436

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002786436

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWR Wipo information: refused in national office

Ref document number: 2002786436

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002786436

Country of ref document: EP